SRI BALAJI MARBLES & GRANITES

Q3 results 2026: BSE, Titan, M&M, HUL, ONGC among 1600 companies to declare earnings next week; check full list here

BSE, Titan, Mahindra & Mahindra, Hindustan Unilever, ONGC, Coal India, Ashok Leyland, Lenskart Solutions, Torrent Pharma among marquee companies to declare Q3 results next week.

Piramal Pharma moves SC against Gujarat pollution body's plant closure order

Piramal Pharma's plea is slated to be heard on 9 February before a bench led by Chief Justice of India Surya Kant, along with Justices…

11 penny stocks surged up to 300% in 3 months. Do you own any?

US trade deal framework to boost investor confidence, strength capital flows, deepen markets: BSE chief

The successful conclusion of an interim trade framework agreement between India and the US will boost investor confidence, strengthen the foundation for capital flows, and…

FPIs turn net buyers in Feb; invest Rs 8,100 cr in a week on US trade deal

After three consecutive months of heavy selling, foreign portfolio investors (FPIs) turned net buyers in the first week of February, infusing more than Rs 8,100…

Inflation data, Q3 earnings likely to drive stock markets this week

Inflation data, trading activity of foreign investors and global trends would dictate sentiment in the stock market this week, according to analysts. Besides, geopolitical developments…

Mcap of 8 of top 10 valued firms surges by whopping Rs 4.55 lakh cr; Reliance biggest winner

The combined market valuation of eight of the top 10 valued firms jumped by a whopping Rs 4.55 lakh crore last week, with Reliance Industries…

Bajaj Finance vs Jio Financial Services: Which stock to buy after Q3 results 2026? Explained

According to market experts, Seema Srivastava, Senior Research Analyst at SMC Global Securities, Bajaj Finance and JFSL present contrasting investment propositions, reflecting different stages of…

Fractal Analytics’ 70x IPO: Why India’s top AI bet is debuting at a 26% discount

India’s first pure-play AI IPO comes at a 26% discount. But behind the 70x multiple lie sticky global clients, volatile margins, and a founder-led model…

Sun Pharma to maintain disciplined approach for acquisitions: Chairman

Sun Pharma will maintain a disciplined approach when it comes to acquisitions in order to allow the business to grow organically while remaining attractive for…

FPIs turn net buyers in Feb, invest ₹8,100 cr in a week on US trade deal

After three consecutive months of heavy selling, foreign portfolio investors (FPIs) turned net buyers in the first week of February, infusing more than Rs 8,100…